AcuCort Update on Phase 4 Study: 10 Patients Recruited
AcuCort's Phase IV study ZEQ001 for Zeqmelit® is progressing as expected. The tenth patient has been allocated the oral film for use when needed for the treatment of acute allergic reactions.As previously communicated, the Phase IV study ZEQ001 regarding the oral film Zeqmelit® commenced at the end of January. The purpose of the study is to collect scientific data related to the launch in the Nordic region from practical experience of patients. The recruitment of patients for the study meets AcuCort's high expectations. Already after one week, ten allergy patients are included in the study,